BOTHELL, Wash.--(BUSINESS WIRE)--Nov 2, 2023--Seagen Inc. (NASDAQ: SGEN) today announced that 12- and 24-month progression free survival data will be presented for an ADCETRIS 庐 (brentuximab vedotin) and immunotherapy combination in early and advanced stage classical Hodgkin lymphoma (cHL), ...
NEW YORK--(BUSINESS WIRE)--Nov 2, 2023--<a ...
All the chairs in the waiting room were filled by dozens of newly arrived migrants waiting to be seen by a Cook County health worker at a clinic in Chicago. Julio Figuera, 43, was among them.He didn鈥檛 want to talk much about traveling to Chicago from Venezuela, where a social, political and ...
BOSTON--(BUSINESS WIRE)--Nov 2, 2023--<em>Myomo, Inc. (NYSE American: MYO)</em> (鈥淢yomo鈥� or the 鈥淐ompany鈥�), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov 2, 2023--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the publication of abstracts from the IMerge Phase 3 clinical trial evaluating its first-in-class investigational telomerase inhibitor imetelstat ...
UPPER NYACK, N.Y.--(BUSINESS WIRE)--Nov 2, 2023--ESI and CVS Health continue to expose hundreds of thousands of patients to the risks of taking medicines their doctor did not prescribe, according to an existing peer-reviewed and updated study, and new research by the Global Healthy Living ...
